TP53 and neuroblastoma: Molecular aberrations in neuroblastoma including amplification of MYCN, deletions of chromosome arm 1p (del1p) or mutations in p53 or anaplastic lymphoma kinase (ALK) are commonly found in advanced stage or relapsed tumors and are associated with an adverse outcome [21-25].